ADAGIO MEDICAL HOLDINGS, INC. Selling, General and Administrative Expense
ADAGIO MEDICAL HOLDINGS, INC. (ADGM) reported Selling, General and Administrative Expense of $2.48 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-11
- ADAGIO MEDICAL HOLDINGS, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $2.48M, a 3.33% increase year-over-year.
- ADAGIO MEDICAL HOLDINGS, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $2.46M, a 29.44% decline year-over-year.
- ADAGIO MEDICAL HOLDINGS, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $1.68M.
- ADAGIO MEDICAL HOLDINGS, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $2.92M.
- ADAGIO MEDICAL HOLDINGS, INC. selling, general and administrative expense for fiscal 2025 was $10.57M.
- ADAGIO MEDICAL HOLDINGS, INC. selling, general and administrative expense for fiscal 2023 was $11.54M.
| Period end | Selling, General and Administrative Expense 1 month | Selling, General and Administrative Expense 2 month | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 5 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 7 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.48M 10-Q · filed 2026-08-11 | $4.94M 10-Q · filed 2026-08-11 | $6.62M derived: sum of 3 quarters · filed 2026-08-11 | $9.53M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $2.46M 10-Q · filed 2026-05-12 | $4.13M derived: sum of 2 quarters · filed 2026-05-12 | $7.05M derived: sum of 3 quarters · filed 2026-05-12 | $9.45M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $4.59M derived: sum of 2 quarters · filed 2026-03-27 | $7.00M derived: sum of 3 quarters · filed 2026-08-11 | $10.57M 10-K · filed 2026-03-27 | ||||
| 2025-09-30 | $2.92M 10-Q · filed 2025-11-12 | $5.32M derived: sum of 2 quarters · filed 2026-08-11 | $8.89M 10-Q · filed 2025-11-12 | |||||
| 2025-06-30 | $2.40M 10-Q · filed 2026-08-11 | $5.98M 10-Q · filed 2026-08-11 | ||||||
| 2025-03-31 | $3.48M 10-Q · filed 2026-05-12 | |||||||
| 2024-12-31 | $6.98M 10-K · filed 2026-03-27 | |||||||
| 2024-09-30 | $2.93M 10-Q · filed 2025-11-12 | |||||||
| 2024-07-30 | $4.85M 10-Q · filed 2025-11-12 | $13.05M 10-K · filed 2026-03-27 | ||||||
| 2024-06-30 | $3.37M 10-Q · filed 2025-08-14 | $8.20M 10-Q · filed 2025-08-14 | $11.50M derived: sum of 3 quarters · filed 2025-08-14 | $15.95M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $4.83M 10-Q · filed 2025-05-15 | $8.13M derived: sum of 2 quarters · filed 2025-05-15 | $12.58M derived: sum of 3 quarters · filed 2025-05-15 | |||||
| 2023-12-31 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $7.75M derived: sum of 2 quarters · filed 2025-03-27 | $11.54M 10-K · filed 2025-03-27 | |||||
| 2023-09-30 | $4.45M 10-Q · filed 2024-11-14 | $8.23M 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |